Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy.
Am J Trop Med Hyg
; 103(5): 1983-1985, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-771325
ABSTRACT
COVID-19 has now spread globally, and 10-20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. After 1 month of prolonged fever, the patient's respiratory condition deteriorated rapidly, and he died. COVID-19 in immunocompromised patients after chemotherapy, even with mild symptoms, can cause rapid immune reconstitution and respiratory deterioration. Therefore, caution is advised until negative PCR test results for SARS-CoV-2 are confirmed.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cross Infection
/
Lymphoma, Mantle-Cell
/
Bone Marrow Failure Disorders
/
SARS-CoV-2
/
COVID-19
Type of study:
Case report
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Am J Trop Med Hyg
Year:
2020
Document Type:
Article
Affiliation country:
Ajtmh.20-0678
Similar
MEDLINE
...
LILACS
LIS